Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review

INTRODUCTION: Etanercept (ETN), a highly effective biological agent for the treatment of psoriasis (PSO) and psoriatic arthritis (PsA), is widely used in Spain. However, evidence of its economic impact is limited, indicating the need for a systematic review of the economic assessments conducted on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Puig, Lluís, Fernández-Freire, Lourdes Rodríguez, Burgos-Pol, Ramón, Gomez, Ismael, Peral, Carmen, Gomez, Susana, Rebollo Laserna, Francisco José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704195/
https://www.ncbi.nlm.nih.gov/pubmed/31062222
http://dx.doi.org/10.1007/s13555-019-0301-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704195/
https://www.ncbi.nlm.nih.gov/pubmed/31062222
http://dx.doi.org/10.1007/s13555-019-0301-6

Ejemplares similares